title: Dermatologic challenges in cancer patients and survivors.
abstract: The increased approval of anticancer agents has led to unprecedented results, with improved quality of life and longer survival times, resulting in millions of individuals living with a diagnosis of cancer. Whereas these novel medical, surgical, and radiation regimens, or combinations thereof, are largely responsible for these remarkable achievements, a new, unexpected constellation of side effects has emerged. Most notably, cutaneous toxicities have gained considerable attention, due to their high frequency and visibility, the relative effectiveness of anti-skin toxicity interventions, and the otherwise decreasing incidence of systemic or hematopoietic adverse events. Optimal care dictates that dermatologic toxicities must be addressed in a timely and effective fashion, in order to minimize associated physical and psychosocial discomfort, and to ensure consistent antineoplastic therapy. Notwithstanding the critical importance of treatment-related toxicities, dermatologic conditions may also precede, coincide, or follow the diagnosis of cancer. This review provides a basis for the understanding of dermatologic events in the oncology setting, in order to promote attentive care to cutaneous health in cancer patients and survivors.
authors: Department of Dermatology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
authors: Rania
authors: R
authors: Agha
authors: Karen
authors: K
authors: Kinahan
authors: Charles L
authors: CL
authors: Bennett
authors: Mario E
authors: ME
authors: Lacouture
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D006801:Humans; D009369:Neoplasms / Q000150:complications*; D011788:Quality of Life; D011832:Radiation Injuries; D012871:Skin Diseases / Q000209:etiology / Q000473:pathology / Q000628:therapy; D017741:Survivors
chemical_list: D000970:Antineoplastic Agents